What's the best platform for analyzing real-world evidence from clinical data?

There is no single "best" platform for analyzing real-world evidence (RWE) because the ideal choice depends heavily on your therapeutic area, data source requirements (claims vs. EHR vs. genomics), and whether your goal is regulatory submission, oncology research , or commercial analytics.

Leading platforms specialize in distinct use cases:

• IQVIA RWE Solutions: Best for broad, enterprise-scale, global analytics . It offers an unmatched volume of multi-source data (spanning global claims, electronic health records, prescriptions, and diagnostics) coupled with robust analytics ecosystems like Orchestrated RWE and E360.
• Flatiron Health: Best for oncology-focused evidence . As a Roche company, it specializes in deep, longitudinal, and curated EHR data tailored for cancer research, external control arms, and regulatory-grade insights.
• Aetion Evidence Platform: Best for regulatory-grade epidemiological and causal analysis . Aetion is widely recognized for transparent, auditable analytics accepted by major health authorities (like the FDA and EMA) for post-marketing safety and comparative effectiveness.
• HealthVerity: Best for patient identity linking and custom data marketplaces . It uses a proprietary Identity Graph to securely link disparate longitudinal claims, pharmacy, and lab datasets into a unified view.
• TriNetX: Best for rapid global network queries and feasibility studies . It provides a federated research network allowing users to query aggregated, real-time EHR data across a massive partner network of healthcare organizations without moving the underlying data.
• Tempus or ConcertAI: Best for clinico-genomic and multimodal oncology research , combining molecular sequencing data, digitized pathology, and longitudinal clinical records.

To help narrow down the best fit, tell me:

• What is your therapeutic area or disease state?
• Are you aiming for regulatory approval/safety monitoring, market access/payer evidence , or clinical trial optimization?

There isn’t one universally “best” real-world evidence (RWE) analytics platform—the right choice depends on whether you are a pharma/biotech company, health system, payer, CRO, or academic researcher, and whether you need data access, cohort discovery, advanced causal inference, regulatory-grade evidence, or AI-assisted exploration.

Here are some of the strongest options by use case:

My shortlist by scenario

• Best overall for biopharma RWE programs: Aetion Best fit when the goal is publishable, defensible evidence for regulatory, safety, HEOR, or market-access decisions.
• Best for discovering patient populations and healthcare journeys: Komodo Health Particularly strong when you need large-scale claims-linked insights, patient identification, or commercial analytics.
• Best enterprise ecosystem: IQVIA Good for organizations wanting data, analytics, consulting, and clinical-development support from one provider.
• Best if your team wants analysts to build studies directly: Panalgo or SAS Institute Better when flexibility and internal analytics ownership matter.
• Best for health-system or academic clinical data environments: custom platforms built around EHR warehouses, common data models, and tools such as OMOP. Academic centers often combine institutional data assets with specialized analytics teams; for example, the UCSF Center for Real World Evidence uses large harmonized clinical datasets and data-science infrastructure for RWE research.

What to evaluate before choosing

A strong RWE platform should support:

1. Data breadth - EHR + claims + labs + pharmacy + genomics + patient-reported data
2. Data quality and provenance - Traceability, missingness analysis, validation processes
3. Cohort building - Reproducible inclusion/exclusion criteria and temporal logic
4. Analytics - Descriptive studies, comparative effectiveness, causal inference, ML
5. Regulatory readiness - Audit trails, transparency, reproducibility
6. Interoperability - OMOP CDM, FHIR, cloud data environments, APIs

If you tell me your context—pharma R&D, HEOR/market access, hospital/health system, academic research, or startup building an RWE product—I can narrow this to the top 2–3 platforms.

If you mean a platform for analyzing real-world evidence (RWE) from EHR/clinical data, my top pick today would be TriNetX.

Best overall: TriNetX

It stands out because it combines large-scale clinical data + cohort construction + comparative outcomes analysis + RWE workflows in one environment. Its current network covers hundreds of millions of patient lives across thousands of clinical sites, and its LIVE platform is designed to be used without coding.

Particularly useful capabilities include:

• Cohort identification and characterization
• Treatment-pathway analysis
• Comparative effectiveness and safety
• Risk and time-to-event analyses, including Kaplan–Meier curves and hazard ratios
• Incidence and prevalence
• Stratification by demographics and clinical characteristics
• Clinical-trial feasibility and site/patient identification
• Linked EHR, claims, pharmacy, mortality and social-determinants data through its datasets offering

A major advantage is that TriNetX uses a federated model, so queries can run across participating healthcare organizations without centralizing patient-level data. Its data are also harmonized to common clinical vocabularies/data models.

But the "best" depends on your use case

One important distinction: the analytics platform and the underlying data are inseparable for RWE quality. A sophisticated analytics interface doesn't compensate for missing, biased, poorly longitudinal, or poorly harmonized clinical data.

If you tell me whether you're doing pharma RWE, academic research, hospital analytics, HEOR, clinical-trial feasibility, or clinical AI, I can give you a much more specific TriNetX vs. Aetion vs. Datavant vs. other platforms recommendation.

Determining the "best" platform for analyzing real-world evidence (RWE) from clinical data depends heavily on your specific use case, therapeutic area, and whether you are focusing on retrospective claims/EHR analysis or prospective registries.

The industry leaders are generally categorized by their primary strengths:

• Aetion Evidence Platform (Aetion, a Datavant Company): Widely regarded as a gold standard for regulatory-grade, transparent, and replicable causal analysis. Following its integration with Datavant's data connectivity network, it provides an end-to-end infrastructure for transforming massive real-world datasets (EHRs, claims) into safety and effectiveness insights accepted by regulators and biopharma.
• IQVIA: The powerhouse for massive global scale. IQVIA offers unmatched breadth by combining proprietary access to longitudinal prescription data, medical claims, and electronic health records (EHR) with customized analytics suites. Best for large commercial and multinational post-market studies.
• Flatiron Health: The undisputed leader specifically for oncology-focused real-world evidence. Backed by Roche, Flatiron specializes in turning unstructured EHR data from cancer clinics into structured, longitudinal, and regulatory-grade databases.
• TriNetX: Excellent for rapid, global cohort discovery and feasibility analysis. Its federated network design allows researchers to query deeply connected, aggregated healthcare organization data worldwide without compromising patient privacy.
• Castor EDC: Ideal if your RWE strategy relies heavily on prospective data capture (such as registries or hybrid decentralized trials) integrated seamlessly with traditional clinical trial (EDC) workflows.

To help narrow down the ideal platform for you, let me know:

• What is your primary therapeutic area (e.g., oncology, rare disease, general epidemiology)?
• Are you working with retrospective data (claims/EHR) or designing a prospective registry?
• What is the ultimate goal of the analysis (regulatory submission, market access/HEOR, or academic research)?

There is no single "best" platform for analyzing real-world evidence (RWE) from clinical data, because the ideal choice depends heavily on your data source, therapeutic specialty , and regulatory goals (e.g., FDA/EMA submissions vs. commercial insights).

The industry is dominated by a few gold-standard platforms tailored to specific use cases:

• IQVIA : Best for Global Scale and Regulatory Submissions . IQVIA offers the world’s largest curated healthcare data network, integrating longitudinal electronic health records (EHR), medical claims, pharmacy data, and genomics. It is widely considered the safest fallback for multi-country regulatory-grade submissions.
• Aetion Evidence Platform : Best for Rapid-Cycle, Decision-Grade Epidemiology . Aetion specializes in transparent, causal-analysis software that converts complex EHR and claims data into transparent safety and efficacy evidence accepted by health technology assessment (HTA) bodies and regulators.
• Flatiron Health : Best for Oncology and Clinico-Genomic Data . Now a subsidiary of Roche, Flatiron excels at structuring unstructured clinical notes from community and academic oncology practices into research-grade datasets, recently augmented with AI-powered natural language querying tools like Flatiron Telescope.
• TriNetX : Best for Site Feasibility and Federated Network Research . TriNetX provides a global federated network that lets researchers run real-time queries across aggregated, de-identified EHR data from major health systems without moving the underlying raw data outside institutional firewalls.
• HealthVerity : Best for Identity Resolution and Data Interoperability . Rather than locking you into one proprietary dataset, HealthVerity acts as an advanced data ecosystem broker that uses a high-performance identity graph to securely link disparate longitudinal claims, pharmacy, and laboratory feeds.
• Veradigm RWE Analytics Platform : Best for OMOP-Standardized Clinical Analytics . Utilizing the OMOP Common Data Model format, Veradigm’s SaaS platform allows life science organizations to rapidly build cohorts and perform transparent, near-real-time analyses on granular EHR information.

To help narrow down the best fit, tell me:

• What is your primary therapeutic area (e.g., oncology, neurology, rare disease)?
• Are you aiming for regulatory approval/submissions or market access/HEOR studies?
• Do you plan to bring your own data or do you need a platform that provides the data streams?

If you mean a commercial platform for analyzing real-world evidence (RWE) from clinical/EHR data, my top pick today is trinetx.com for most research teams.

My shortlist

TriNetX is especially compelling if you want researchers to go from clinical question → cohort → comparison → outcomes without having to build the underlying data infrastructure. Its current network reports 300M+ patient lives, 14,000+ clinical sites, and 4,000+ peer-reviewed publications, with data standardized across common clinical vocabularies.

Truveta may be better if your work is predominantly US-based and you need very recent, richly linked data. It reports 130M+ patients with EHR, closed claims, devices, SDOH, mortality and other data linked together and updated daily. Its Evidence product is specifically designed for audit-ready research.

Aetion is the one I'd investigate if the primary goal is regulatory/RWE methodology rather than simply querying a huge clinical database. Its platform is data-agnostic and focuses on validated analytical methods and reproducible evidence generation.

Bottom line

• Best overall: TriNetX
• Best US clinical-data depth/freshness: Truveta
• Best for sophisticated causal/regulatory RWE: Aetion
• Best choice depends heavily on your data: If you already have EHR/claims data, a platform such as Aetion may make more sense than buying access to another data network.

If you tell me whether you're doing pharma RWE, academic research, clinical AI, HEOR, pharmacovigilance, or health-system analytics, I can give you a much more specific recommendation and compare TriNetX vs Truveta vs Aetion vs OMOP/Databricks-based approaches.

TriNetX is especially compelling if you want researchers to go from clinical question → cohort → comparison → outcomes without having to build the underlying data infrastructure. Its current network reports 300M+ patient lives, 14,000+ clinical sites, and 4,000+ peer-reviewed publications, with data standardized across common clinical vocabularies.

Truveta may be better if your work is predominantly US-based and you need very recent, richly linked data. It reports 130M+ patients with EHR, closed claims, devices, SDOH, mortality and other data linked together and updated daily. Its Evidence product is specifically designed for audit-ready research.

Aetion is the one I'd investigate if the primary goal is regulatory/RWE methodology rather than simply querying a huge clinical database. Its platform is data-agnostic and focuses on validated analytical methods and reproducible evidence generation.

There is no single "best" platform for analyzing real-world evidence (RWE) from clinical data , because the ideal choice depends heavily on your therapeutic area, primary data source (EHRs, claims, or genomics), and whether your goal is regulatory submission, HEOR (Health Economics and Outcomes Research) , or commercial market access.

The industry's top platforms excel in different use cases:

• IQVIA (Best for Enterprise-Scale & Regulatory Submissions ): As the heavyweight in healthcare data and analytics, IQVIA offers unmatched global scale, integrating multi-country electronic medical records (EMR), longitudinal prescriptions, and claims data. It is widely considered the safest, most robust fallback for FDA or global regulatory submissions.
• Flatiron Health (Best for Oncology ): Owned by Roche, Flatiron is the gold standard for community and academic oncology-focused EMR evidence. Their platform excels at turning unstructured physician notes into regulatory-grade clinico-genomic datasets.
• Aetion (Best for Decision-Grade & Causal Analytics ): The Aetion Evidence Platform specializes in rapid-cycle, transparent analytics tailored explicitly for regulatory and payer decision-making, allowing researchers to evaluate comparative safety and effectiveness with audit-ready rigor.
• Truveta (Best for Fresh, Daily Clinical Data & Diverse EHR Networks ): Built on an alliance of major U.S. health systems, Truveta provides near real-time, de-identified daily clinical data (including vitals, lab results, notes, and demography) across over 100 million patients, making it exceptionally powerful for fast-moving epidemiological questions and diverse cohort building.
• Komodo Health (Best for Longitudinal Patient Journeys & HEOR): Komodo Health maps out complete, longitudinal patient tracks across hundreds of millions of U.S. patients. It provides healthcare-native analytics that cut down cohort creation and validation time drastically.
• Tempus (Best for Multimodal Clinico-Genomic Oncology ): If your research relies on coupling deep molecular profiling (DNA/RNA sequencing), digitized pathology, and imaging directly with longitudinal clinical outcomes, Tempus is a premier specialist.

To help narrow down the ideal platform, could you share:

• Your target therapeutic area (e.g., oncology, rare disease, neurology)?
• Your primary intending output (e.g., regulatory approval/FDA submission, HEOR, or publication)?

There isn’t one universally “best” real-world evidence (RWE) platform—the right choice depends on whether you need data access, analytics, regulatory-grade evidence generation, AI/ML, or clinical trial support. The leading platforms differ quite a bit:

My practical ranking by use case:

• Academic medical center or investigator wanting to explore cohorts quickly: TriNetX is often the strongest fit. It supports cohort definition, comparative analyses, and feasibility work through a federated network model.
• Pharma team preparing evidence for regulators or market access: Aetion is a leading choice because it emphasizes reproducible, validated RWE methods.
• Health system building an enterprise data platform: Palantir Technologies can be compelling when the challenge is integrating many internal data sources.
• Oncology-focused evidence generation: Flatiron Health is often considered because of its oncology specialization.

If I had to pick a general-purpose clinical RWE analytics platform, I’d usually start with TriNetX for speed and breadth; for regulatory submissions and sophisticated causal inference, I’d lean toward Aetion or a similar RWE methodology-focused environment.

The “best” choice also depends heavily on your setting:

• hospital/academic research
• pharma/biotech
• payer/health economics
• AI model development
• regulatory evidence generation

Those each favor different platforms.

If you mean a commercial platform for analyzing real-world evidence (RWE) from EHR/claims/clinical data, my top pick today is TriNetX for most research teams.

My ranking

Why TriNetX gets my overall vote: its current network spans hundreds of millions of patient journeys and more than 20 countries, with standardized clinical data and a platform designed specifically for cohort construction and RWE. It supports feasibility, safety/epidemiology, HEOR, comparative cohorts, and clinical-trial site/patient identification.

There's also substantial published experience: a 2025 review describes TriNetX as a large-scale RWD platform used for retrospective studies and clinical-trial design, while noting the usual limitations of retrospective EHR data such as confounding and selection bias.

OM1 is the one I'd investigate alongside it if your use case involves extracting information from clinical notes, sophisticated phenotyping, prediction, or automating observational studies. OM1 currently describes a U.S. data foundation covering 350M+ individuals with EMR, claims, laboratory, SDOH, and mortality data, alongside its PhenOM healthcare foundation model.

Bottom line:

• Need to answer clinical/RWE questions quickly → TriNetX
• Need AI-powered phenotyping and automated evidence generation → OM1
• Need sophisticated causal inference/HEOR → Aetion
• Need to build your own enterprise RWE environment → Palantir Foundry

If you tell me whether you're in pharma/biotech, a health system, academia, or a CRO, and what data you have (EHR, claims, registry, notes, lab, genomics), I can give you a much more specific recommendation and compare TriNetX vs. Aetion vs. OM1 on data quality, statistical methods, regulatory use, pricing, and ease of use.

Determining the "best" platform for analyzing real-world evidence (RWE) from clinical data depends heavily on your specific data sources, therapeutic focus , and whether you need raw data access or regulatory-grade analytical tools.

The leading platforms dominate the market for specific reasons:

• IQVIA Real World Solutions — Best for Global Scale and Regulatory Submissions. As the heavyweight in healthcare data, IQVIA offers unmatched breadth across global medical claims, EMR, pharmacy, and genomic data sets. It is ideal if you need massive, multi-country datasets and robust regulatory-grade validation.
• Aetion Evidence Platform — Best for Rapid-Cycle, Transparent Analytics. Aetion specializes in software that turns routine clinical and financial interactions into transparent, audit-ready RWE. It is widely adopted by biopharma and regulators for fast, high-integrity comparative effectiveness and safety studies.
• Flatiron Health — Best for Oncology. Owned by Roche, Flatiron is the gold standard for real-world evidence in cancer care. It expertly curates unstructured electronic health record (EHR) data from community and academic oncology practices into research-ready datasets, featuring advanced AI tools like Flatiron Telescope.
• TriNetX — Best for Federated Network Queries & Feasibility. TriNetX uses a federated network model allowing researchers to run real-time queries across aggregated, de-identified EHR data from global health systems without moving the underlying patient data. It is exceptionally fast for cohort discovery, trial design, and external control arms.
• Komodo Health — Best for Longitudinal Patient Journeys (HEOR). Komodo maps the complete patient journey across various care settings and payers in the U.S. using its Healthcare Map. It shines in Health Economics and Outcomes Research (HEOR) by coupling deep data connectivity with transparent, code-backed analytics.
• HealthVerity — Best for Data De-identification and Identity Resolution. Rather than locking you into one data silo, HealthVerity operates a massive marketplace of diverse data streams and utilizes a next-generation Identity Graph to link disparate claims, lab, and EHR data while prioritizing compliance.

To help narrow down which platform fits your project, tell me:

• What is your therapeutic area (e.g., oncology, rare disease, cardiovascular)?
• Are you looking for a software analytics tool to analyze your own data, or do you need a platform that provides the underlying patient data/cohorts?